Plasma human immunodeficiency virus (HIV) type 1 RNA load in men and women with advanced HIV-1 disease

被引:12
作者
Kalish, LA
Collier, AC
Flanigan, TP
Kumar, PN
机构
[1] New England Res Inst, Watertown, MA 02472 USA
[2] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
[3] Brown Univ, Miriam Hosp, Dept Med, Providence, RI USA
[4] Georgetown Univ, Med Ctr, Dept Med, Washington, DC 20007 USA
关键词
D O I
10.1086/315710
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several studies of patients infected with human immunodeficiency virus (HIV) type 1 have suggested that women have lower plasma HIV-1 RNA levels than men, even when controlling for CD4 T cell levels. A cross-sectional analysis was performed in 494 patients (21% of whom were women) who enrolled in a prospective study of anemic HIV-1-infected patients requiring transfusion. The median CD4 T cell count and plasma HIV-1 RNA levels were 15 cells/mu L and 4.83 log(10) copies/mL (67,350 copies/mL), respectively. In unadjusted analyses, women had slightly higher mean log HIV-1. RNA titers than men (0.19 log(10) higher copieslml; 95% confidence interval, -0.05 to 0.44; P = .11), Adjustment for CD4 T cell count, race or ethnicity, injection drug use, and age yielded a smaller sex difference (0.13 log(10) copieslml higher in women; P = .28), In this population of patients with very advanced HIV disease, there is no evidence that women have lower HIV-1 RNA levels than men.
引用
收藏
页码:603 / 606
页数:4
相关论文
共 16 条
[1]  
ANASTOS K, 1999, 6 C RETR OPP ILLN CH, P120
[2]   The viral activation transfusion study (VATS): Rationale, objectives, and design overview [J].
Busch, MP ;
Collier, A ;
Gernsheimer, T ;
Carrington, JD ;
Flanigan, TP ;
Kashkari, M ;
Kennedy, M ;
Kumar, PN ;
Lane, TA ;
Mellors, JW ;
Mohandas, K ;
Pollard, RB ;
Viele, M ;
Yomtovian, R ;
Holland, PV ;
McCurdy, PR .
TRANSFUSION, 1996, 36 (10) :854-859
[3]   Gender is not a factor in serum human immunodeficiency virus type 1 RNA levels in patients with viremia [J].
Bush, CE ;
Donovan, RM ;
Markowitz, N ;
Baxa, D ;
Kvale, P ;
Saravolatz, LD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) :970-972
[4]  
*CDCP, 1998, MMWR-MORBID MORTAL W, V47, P6
[5]   Serum levels of virus burden in early-stage human immunodeficiency virus type 1 disease in women [J].
Evans, JS ;
Nims, T ;
Cooley, J ;
Bradley, W ;
Jagodzinski, L ;
Zhou, S ;
Melcher, GP ;
Burke, DS ;
Vahey, M .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (04) :795-800
[6]   Sex differences in HIV-1 viral load and progression to AIDS [J].
Farzadegan, H ;
Hoover, DR ;
Astemborski, J ;
Lyles, CM ;
Margolick, JB ;
Markham, RB ;
Quinn, TC ;
Vlahov, D .
LANCET, 1998, 352 (9139) :1510-1514
[7]  
Fiebig EW, 1997, CYTOMETRY, V29, P340, DOI 10.1002/(SICI)1097-0320(19971201)29:4<340::AID-CYTO11>3.0.CO
[8]  
2-U
[9]   Impact of the ovulatory cycle on virologic and immunologic markers in HIV-infected women [J].
Greenblatt, RM ;
Ameli, N ;
Grant, RM ;
Bacchetti, P ;
Taylor, RN .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (01) :82-90
[10]  
Junghans C, 1999, LANCET, V353, P589, DOI 10.1016/S0140-6736(05)75645-2